The iwNHL Meeting is in its 20th year, advancing since the success of the inaugural meeting in 2014.
iwNHL is led by world-leading clinical experts in the field of lymphoma, who, each year, put together a comprehensive agenda covering novel therapeutic strategies, addressing frontline challenges and optimizing patient care.
The workshop features presentations from an invited faculty of highly-respected clinicians and researchers around the world, followed by opportunities for Q&A panel discussions following each topic session.
The continued success of the iwNHL meeting is in no small part due to the ongoing support of sponsors, allowing a unique opportunity for clinicians to be brought together to facilitate interactive and stimulating debates to help improve patient outcomes.
iwNHL 2022 was supported by: